◀ Back to NFKB1

NFKB1 — S100A12

Text-mined interactions from Literome

Millet et al., J Biol Chem 2000 : CGRP inhibits the accumulation of NF-kappaB complexes in the nucleus by preventing phosphorylation and degradation of the NF-kappaB inhibitor IkappaB
Hou et al., J Neurosci Res 2003 : The inhibitors of PKC, JNK MAPK and NF-kappaB , but not p38 or ERK1/2 MAPK, blocked IL-1beta induced CGRP release
Li et al., Am J Physiol Cell Physiol 2006 : Subsequent investigation revealed that CGRP inhibited IL-1beta evoked NF-kappaB activity by suppressing IkappaBalpha phosphorylation and degradation ... We previously showed that the CGRP inhibitory effect was mediated by elevated intracellular cAMP and show here that analogs of cAMP, 8-bromoadenosine 3',5'-cyclic monophosphothioate and the Sp isomer of adenosine 3',5'-cyclic monophosphothioate, mimicked the CGRP suppressive effect on IL-1beta induced ROS formation, NF-kappaB activation, and MCP-1 secretion
Srikrishna et al., J Cell Biochem 2010 : mAbGB3.1, an antibody against carboxylated glycans, blocks S100A12 mediated NF-kappaB signaling in HeLa cells expressing full-length RAGE
McGillis et al., Can J Physiol Pharmacol 1995 : To determine whether the inhibitory effects of CGRP on sIg expression are mediated by an inhibition of NF kappa-B translocation to the nucleus, electrophoretic mobility shift assays were performed using nuclear proteins from 70Z/3 cells ... There was no difference in NF kappa-B binding activity in cells that had been treated with LPS or LPS + CGRP, suggesting that the inhibitory effect of CGRP is not mediated by an inhibition of NF kappa-B activity